<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Larabee SM</submitter><funding>BLRD VA</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><funding>U.S. Department of Veterans Affairs</funding><pagination>e0269618</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9165902</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(6)</volume><pubmed_abstract>Overexpression of M3 subtype muscarinic receptors (M3R) hastens colon cancer progression. As microRNA (miRNA) expression is commonly dysregulated in cancer, we used microarrays to examine miRNA profiles in muscarinic receptor agonist-treated human colon cancer cells. We used quantitative RT-PCR (qPCR) to validate microarray results and examine miRNA expression in colon cancers and adjacent normal colon. These assays revealed that acetylcholine (ACh) treatment robustly induced miR-222 expression; miR-222 levels were three-fold higher in cancer compared to normal colon. In kinetic studies, ACh induced a 4.6-fold increase in pri-miR-222 levels within 1 h, while mature miR-222 increased gradually to 1.8-fold within 4 h. To identify post-M3R signaling mediating these actions, we used chemical i</pubmed_abstract><journal>PloS one</journal><pubmed_title>Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.</pubmed_title><pmcid>PMC9165902</pmcid><funding_grant_id>BX004890</funding_grant_id><funding_grant_id>DK067872</funding_grant_id><funding_grant_id>T32 DK067872</funding_grant_id><funding_grant_id>I01 BX004890</funding_grant_id><pubmed_authors>Hu S</pubmed_authors><pubmed_authors>Cheng K</pubmed_authors><pubmed_authors>Larabee SM</pubmed_authors><pubmed_authors>Raufman JP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.</name><description>Overexpression of M3 subtype muscarinic receptors (M3R) hastens colon cancer progression. As microRNA (miRNA) expression is commonly dysregulated in cancer, we used microarrays to examine miRNA profiles in muscarinic receptor agonist-treated human colon cancer cells. We used quantitative RT-PCR (qPCR) to validate microarray results and examine miRNA expression in colon cancers and adjacent normal colon. These assays revealed that acetylcholine (ACh) treatment robustly induced miR-222 expression; miR-222 levels were three-fold higher in cancer compared to normal colon. In kinetic studies, ACh induced a 4.6-fold increase in pri-miR-222 levels within 1 h, while mature miR-222 increased gradually to 1.8-fold within 4 h. To identify post-M3R signaling mediating these actions, we used chemical i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T18:36:36.408Z</modification><creation>2025-02-19T04:57:37.525Z</creation></dates><accession>S-EPMC9165902</accession><cross_references><pubmed>35657974</pubmed><doi>10.1371/journal.pone.0269618</doi></cross_references></HashMap>